Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-21

FDA Approved: FULVESTRANT — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application from Amneal Pharmaceuticals LLC for Fulvestrant (generic), under ANDA210044, indicating approval of a generic Fulves…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

SUPPL AP for FULVESTRANT (FULVESTRANT)